GKOS · XBRL financial data
GLAUKOS financial statements, every fiscal year
The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (GKOS's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue from contracts with customers | 225 | 294 | 283 | 315 | 383 | 507 |
| Cost of goods and services sold | 92 | 67 | 69 | 76 | 94 | 112 |
| Gross profit | 133 | 227 | 214 | 239 | 289 | 283 |
| Selling, general and administrative | 171 | 179 | 193 | 224 | 261 | 332 |
| Total operating expenses | 257 | 260 | 296 | 368 | 412 | 482 |
| Operating income (loss) | (124) | (33) | (82) | (129) | (122) | (200) |
| Interest expense | 14 | 13 | 14 | 14 | 10 | 5 |
| Other income (expense) | — | — | — | (1) | (6) | 0 |
| Income tax expense (benefit) | (12) | 0 | 1 | 1 | 1 | (5) |
| Net income (loss) | (120) | (50) | (99) | (135) | (146) | (188) |
| Earnings per share, basic USD per share | (2.70) | (1.07) | (2.09) | (2.78) | (2.77) | (3.28) |
| Earnings per share, diluted USD per share | (2.70) | (1.07) | (2.09) | (2.78) | (2.77) | (3.28) |
| Weighted average shares, basic millions of shares | 44 | 46 | 47 | 48 | 53 | 57 |
| Weighted average shares, diluted millions of shares | 44 | 46 | 47 | 48 | 53 | 57 |
Balance sheet
CSVFiscal years (GKOS's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 97 | 101 | 120 | 93 | 170 | 91 |
| Accounts receivable | 36 | 33 | 36 | 40 | 61 | 109 |
| Inventory | 16 | 23 | 38 | 42 | 58 | 64 |
| Prepaid and other current assets | 13 | 16 | 17 | 18 | 12 | 24 |
| Total current assets | 469 | 486 | 444 | 395 | 450 | 475 |
| Property and equipment, net | 24 | 69 | 94 | 103 | 98 | 113 |
| Right-of-use asset | 20 | 28 | 26 | 27 | 30 | 32 |
| Goodwill | 66 | 66 | 66 | 66 | 66 | 67 |
| Total assets | 1,006 | 1,050 | 1,002 | 940 | 975 | 893 |
| Accounts payable | 4 | 7 | 14 | 13 | 13 | 25 |
| Accrued liabilities | 45 | 56 | 58 | 61 | 62 | 77 |
| Total current liabilities | 50 | 63 | 72 | 74 | 75 | 101 |
| Lease liability, non-current | 21 | 30 | 29 | 30 | 34 | 36 |
| Total liabilities | 338 | 463 | 472 | 479 | 208 | 237 |
| Accumulated deficit | (310) | (365) | (464) | (599) | (745) | (933) |
| Total stockholders' equity | 667 | 587 | 530 | 462 | 767 | 656 |
| Total liabilities and equity | 1,006 | 1,050 | 1,002 | 940 | 975 | 893 |
| Common shares outstanding (cover page) millions of shares | 46 | 47 | 48 | 49 | 57 | 58 |
Cash flows
CSVFiscal years (GKOS's year ends in late December)
| In millions of dollars | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | (120) | (50) | (99) | (135) | (146) | (188) |
| Stock-based compensation | 46 | 30 | 39 | 44 | 50 | 63 |
| Depreciation and amortization | 29 | 30 | 32 | 34 | 36 | 38 |
| Net cash from operating activities | (23) | 25 | (33) | (58) | (61) | (15) |
| Purchases of property and equipment | 7 | 48 | 30 | 20 | 6 | 8 |
| Net cash from investing activities | (205) | (58) | 45 | 14 | 48 | (78) |
| Net cash from financing activities | 263 | 39 | 6 | 15 | 92 | 12 |
| Net change in cash | 34 | 4 | 16 | (27) | 75 | (80) |
Compare with peers
SIC 3841 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 3841 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($M) | Revenue, quarter ($M) | Operating cash flow, quarter ($M) | Shares outstanding | Quarter |
|---|---|---|---|---|---|
| GLAUKOS | 162 | 211 | 39* | 59.2M | 10-QSep 30, 2026 |
| Merit Medical Systems | 504 | 416 | 65* | 59.9M | 10-QSep 30, 2026 |
| MSA Safety | 187 | 536 | 82* | 38.5M | 10-QSep 30, 2026 |
| Globus Medical | 508 | 790 | 210* | 134.3M | 10-QJun 30, 2026 |
| iRhythm Holdings | 247 | 224 | 51* | 33.0M | 10-QJun 30, 2026 |
| TransMedics Group | 491 | 190 | 17* | 34.7M | 10-QJun 30, 2026 |
| Integer Holdings | 14 | 450 | 37* | 34.0M | 10-QOct 2, 2026 |
| Masimo | 125 | 404 | 45 | 52.4M | 10-QApr 4, 2026 |
| Inspire Medical Systems | 191 | 207 | 46* | 29.0M | 10-QSep 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.